CH650680A5 - Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. - Google Patents

Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. Download PDF

Info

Publication number
CH650680A5
CH650680A5 CH5011/82A CH501182A CH650680A5 CH 650680 A5 CH650680 A5 CH 650680A5 CH 5011/82 A CH5011/82 A CH 5011/82A CH 501182 A CH501182 A CH 501182A CH 650680 A5 CH650680 A5 CH 650680A5
Authority
CH
Switzerland
Prior art keywords
human
insulin
proinsulin
peptide
composition according
Prior art date
Application number
CH5011/82A
Other languages
German (de)
English (en)
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH650680A5 publication Critical patent/CH650680A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH5011/82A 1981-08-27 1982-08-23 Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. CH650680A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671681A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
CH650680A5 true CH650680A5 (de) 1985-08-15

Family

ID=23143244

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5011/82A CH650680A5 (de) 1981-08-27 1982-08-23 Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin.

Country Status (18)

Country Link
JP (1) JPS5846026A (fr)
AU (1) AU551734B2 (fr)
BE (1) BE894187A (fr)
CA (1) CA1176159A (fr)
CH (1) CH650680A5 (fr)
DE (1) DE3232035A1 (fr)
FR (1) FR2511868B1 (fr)
GB (1) GB2104381B (fr)
IL (1) IL66612A (fr)
IT (1) IT1153183B (fr)
LU (1) LU84357A1 (fr)
MW (1) MW3982A1 (fr)
NL (1) NL8203313A (fr)
NZ (1) NZ201685A (fr)
PH (1) PH18640A (fr)
SE (1) SE8204872L (fr)
ZA (1) ZA826160B (fr)
ZW (1) ZW17682A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
JPS62222379A (ja) * 1986-03-25 1987-09-30 Mutoh Ind Ltd コンピュータグラフィックスにおける隠線・隠面処理方法
US9389582B2 (en) 2014-06-02 2016-07-12 Lexmark International, Inc. Replaceable unit for an image forming device having magnets of varying angular offset for toner level sensing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
SE8204872L (sv) 1983-02-28
NZ201685A (en) 1985-09-13
DE3232035A1 (de) 1983-03-10
ZA826160B (en) 1984-04-25
SE8204872D0 (sv) 1982-08-25
IL66612A (en) 1985-11-29
PH18640A (en) 1985-08-23
FR2511868A1 (fr) 1983-03-04
NL8203313A (nl) 1983-03-16
GB2104381A (en) 1983-03-09
ZW17682A1 (en) 1982-11-24
CA1176159A (fr) 1984-10-16
IT1153183B (it) 1987-01-14
LU84357A1 (fr) 1983-02-28
GB2104381B (en) 1984-12-05
MW3982A1 (en) 1984-06-13
AU8759782A (en) 1983-03-03
IT8223018A1 (it) 1984-02-27
IT8223018A0 (it) 1982-08-27
BE894187A (fr) 1983-02-24
JPS5846026A (ja) 1983-03-17
AU551734B2 (en) 1986-05-08
FR2511868B1 (fr) 1986-05-09

Similar Documents

Publication Publication Date Title
AT408611B (de) Insulinanalogon-protamin-komplex
DE19726167B4 (de) Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
EP2451437B1 (fr) Préparations aqueuses de l'insuline contenant de la méthionine
DE69019534T2 (de) Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.
EP0357978B1 (fr) Préparation pharmaceutique pour le traitement du diabète sucré
AT408720B (de) Parenterale pharmazeutische formulierung eines humaninsulinanalogon-komplexes
DE69428860T2 (de) Insulin Formulierung
DE69807679T2 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DE69434963T2 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE3855970T2 (de) Verwendung von Amylin oder CGRP zur Behandlung des Diabetes mellitus
DE69816409T2 (de) Kristallines Parathyroidhormon
DE69708121T2 (de) Halogenid-enthaltende insulinzubereitungen
DE69027217T2 (de) Behandlung von insulinresistentem diabetes
EP2289539A1 (fr) Préparations d'insuline sans zinc ou pauvre en zinc dotées d'une stabilité améliorée
DE60005806T2 (de) Zusammensetzung auf basis gegensätzlich geladener polypeptide
EP2451471A1 (fr) Préparations d'insuline à effet retard
CH650678A5 (de) Pharmazeutisches mittel aus human-insulin und human-proinsulin.
DE3232034C2 (fr)
EP1084248B1 (fr) Nouveaux analogues de l'insuline presentant un pouvoir de liaison accru avec le zinc
DE69417397T2 (de) Lösung, die igf-1 enthält
CH650677A5 (de) Gegen diabetes mellitus wirksames pharmazeutisches mittel.
CH650680A5 (de) Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin.
DE69231263T2 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
EP0001124A1 (fr) Mélanges de médicaments pour améliorer l'utilisation de glucose dans les cellules et abaisser le taux du sucre dans le sang
DE69710918T2 (de) Topisches präparat zur abgabe eines peptidarzneimittels in lebewesen

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased